Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A SAS/IML program for simulating pharmacokinetic data.

Estelle Russek-Cohen1, Marilyn N Martinez, Anna B Nevius

  • 1Department of Animal and Avian Sciences, University of Maryland, College Park, MD 20742, USA. erussek@umd.edu

Computer Methods and Programs in Biomedicine
|March 23, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initial Exploration on the Application of the MoCMC Approach for Determining In Vitro Product Comparability.

Pharmaceutical research·2026
Same author

Proposed Meropenem Breakpoints for Interpretation of Antimicrobial Susceptibility Testing of Bacteria Isolated From Dogs.

Journal of veterinary pharmacology and therapeutics·2026
Same author

Estimating Risk Differences Using Large Healthcare Data Networks for Medical Product Post-Market Safety Outcomes in a Distributed Data Setting and Allowing for Active Post-Market Surveillance.

Statistics in medicine·2026
Same author

A Top-Down Physiologically Based Pharmacokinetic Modeling Approach to Explore Unexpected Bio-inequivalence of Experimental Oral Formulations in Dogs.

Pharmaceutical research·2026
Same author

The Need for a Revision of Fluoroquinolone Breakpoints for Interpretation of Antimicrobial Susceptibility Testing of Feline Bacterial Isolates.

Journal of veterinary pharmacology and therapeutics·2025
Same author

A Bottom-up Approach for Mutant and Wild Type Collies Using Physiologically Based Pharmacokinetic (PBPK) Modeling: A Case Study Using Loperamide.

The AAPS journal·2025
Same journal

SynTME: A tumor microenvironment-aware, pharmacology-inspired multi-stage framework for drug synergy prediction.

Computer methods and programs in biomedicine·2026
Same journal

MMFVS-Net: A triple-symmetric cross-attention network for multimodal optical image fusion and high-accuracy virtual staining of breast cancer tissues.

Computer methods and programs in biomedicine·2026
Same journal

A novel Milstein-stochastic epidemiologically-informed neural network for approaching epidemic dynamics: Application to Mpox disease.

Computer methods and programs in biomedicine·2026
Same journal

Accounting for approximation errors using surrogate-based parameter estimation of cardiac mechanics digital twins.

Computer methods and programs in biomedicine·2026
Same journal

Facial iPPG heatmap patterns based on period-aware autoencoder show association with carotid atherosclerosis towards non-contact hemodynamic assessment.

Computer methods and programs in biomedicine·2026
Same journal

Explainable machine learning models predict liver fibrosis risk and outcome in the general population: Development and multi-cohort external validation.

Computer methods and programs in biomedicine·2026
See all related articles

Data simulation optimizes bioequivalence trial design for animal health products. A new SAS program generates complex pharmacokinetic datasets, aiding product comparability assessments in veterinary medicine.

Area of Science:

  • Veterinary Pharmacology
  • Biostatistics
  • Pharmacokinetics

Background:

  • Bioequivalence trials are crucial for assessing product comparability in veterinary medicine.
  • Complex experimental situations in veterinary drug development often complicate trial design.
  • Optimizing trial design is essential for accurate and efficient product evaluation.

Purpose of the Study:

  • To develop a novel data simulation program for optimizing bioequivalence trial design.
  • To generate realistic pharmacokinetic datasets reflecting complex veterinary scenarios.
  • To leverage SAS/IML for advanced statistical analysis in animal health product evaluation.

Main Methods:

  • Designed and implemented a SAS/IML program for pharmacokinetic data simulation.

Related Experiment Videos

  • Incorporated kinetic, population, and study design characteristics into the simulation.
  • Utilized SAS statistical capabilities for generating complex datasets.

    • Main Results:

    • Successfully generated diverse pharmacokinetic datasets suitable for bioequivalence trial simulation.
    • The program can model various complex factors encountered in veterinary medicine.
    • Demonstrated the utility of SAS/IML for creating sophisticated simulation tools.

    Conclusions:

    • The developed SAS/IML program is a valuable tool for optimizing bioequivalence trial design in veterinary medicine.
    • Data simulation can effectively address challenges in assessing product comparability for animal health products.
    • This approach enhances the statistical rigor and efficiency of veterinary drug development.